Picture of Orion Oyj logo

ORNBV Orion Oyj Share Price

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-3.59%
3m+12.91%
6m-5.26%
1yr+16.28%
Volume Change (%)
10d/3m-3.46%
Price vs... (%)
52w High-7.77%
50d MA+0.6%
200d MA+5.55%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)18.17
PEG Ratio (f)2.94
EPS Growth (f)6.58%
Dividend Yield (f)2.77%
Valuation (ttm)IndustryMarket
Price to Book Value7.61
Price to Tang. Book8.91
Price to Free Cashflow44.58
Price to Sales5.17
EV to EBITDA14.41

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital43.57%
Return on Equity43.7%
Operating Margin33.43%

Financial Summary

Year End 31st DecUnit202120222023202420252026E2027ECAGR / Avg
Total Revenue€m1,0411,340.61,189.71,542.41,889.52,018.812,232.6811.88%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-13.41+82.85-46.46+92.25+39.05+3.99+16.54n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Orion Oyj EPS forecast chart

Profile Summary

Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.

Directors

Last Annual
December 31st, 2025
Last Interim
December 31st, 2025
Incorporated
July 1st, 2006
Public Since
July 3rd, 2006
No. of Shareholders
91,391
No. of Employees
4,029
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
fi flag iconOMX Nordic Exchange - Helsinki
Shares in Issue
140,693,334

ORNBV Share Price Performance

Upcoming Events for ORNBV

Orion Oyj Annual Shareholders Meeting

Dividend For ORNBV.HE - 0.9000 EUR

Dividend For ORNAV.HE - 0.9000 EUR

Dividend For ORINY.PK - 0.5304 USD

Q1 2026 Orion Oyj Earnings Release

Half Year 2026 Orion Oyj Earnings Release

Similar to ORNBV

Picture of Biohit Oyj logo

Biohit Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Oriola Oyj logo

Oriola Oyj

fi flag iconOMX Nordic Exchange - Helsinki

FAQ